By Mayo Clinic News Network
Syndicated content 

Alzheimer's drug may slow decline


Last updated 1/10/2023 at 5:11pm


It's important to note the new treatment is not intended for all dementia patients -- only those who have mild cognitive impairment or mild dementia due to Alzheimer's disease.

The Food and Drug Administration has granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memo...

For access to this article please sign in or subscribe.


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2023